Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Serkan Abacıoğlu"'
Autor:
Serkan Abacıoğlu, Kemal Aydın, Fatih Büyükcam, Ural Kaya, Bahattin Işık, Muhammed Evvah Karakılıç
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 1, Pp 48-52 (2016)
INTRODUCTION: In the first assessment of trauma patients with major vascular injuries, we need effective and rapid-acting homeostatic materials. In this study we compare the efficiencies of Ankaferd Blood Stopper® and a chitosan linear polymer (Celo
Externí odkaz:
https://doaj.org/article/58ea99d66ca3486c898b204111fea9ac
Autor:
Kemal Aydin, Ural Kaya, Fatih Büyükcam, Bahattin Isik, Serkan Abacıoğlu, Muhammed Evvah Karakılıç
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 1, Pp 48-52 (2016)
Turkish Journal of Hematology
Turkish Journal of Hematology
WOS: 000378165300008
PubMed: 25913214
Objective: In the first assessment of trauma patients with major vascular injuries, we need effective and rapid-acting homeostatic materials. In this study we compare the efficiencies of Ankaferd Blood
PubMed: 25913214
Objective: In the first assessment of trauma patients with major vascular injuries, we need effective and rapid-acting homeostatic materials. In this study we compare the efficiencies of Ankaferd Blood
Autor:
Ozge Ozcan Abacioglu, Arafat Yildirim, Mine Karadeniz, Ferhat Dindas, Serkan Abacioglu, Nermin Yildiz Koyunsever, Mustafa Dogdus
Publikováno v:
Haseki Tıp Bülteni, Vol 60, Iss 2, Pp 145-151 (2022)
Aim:Pulmonary embolism (PE) is a condition caused by thrombosis and is a common cause of death. Although there are studies of PE with CHA2DS2-VASc (C: congestive heart failure or left ventricular systolic dysfunction, H: hypertension, A: age of ≥75
Externí odkaz:
https://doaj.org/article/40292fecee6a4eb194150dfaf1da95ec
Autor:
Ozge Ozcan Abacioglu MD, Arafat Yildirim MD, Mine Karadeniz MD, Serkan Abacioglu MD, Nermin Yildiz Koyunsever MD, Ferhat Dindas MD, Mustafa Dogdus MD, Mustafa Kaplangoray MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Aim to investigate whether the MAPH score, which is a new score that combines blood viscosity biomarkers such as mean platelet volume (MPV), total protein and hematocrit, can be used to predict thrombus burden in ST-segment elevation myocardial infar
Externí odkaz:
https://doaj.org/article/2f9d72be040d4ace9c27066178d94087